HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jos W M van der Meer Selected Research

Schnitzler Syndrome

12/2011Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
5/2011Effects of the histone deacetylase inhibitor ITF2357 in autoinflammatory syndromes.
12/2007Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jos W M van der Meer Research Topics

Disease

38Infection
09/2015 - 01/2002
24Inflammation
02/2015 - 02/2002
13Sepsis (Septicemia)
07/2012 - 12/2002
9Fever (Fevers)
02/2014 - 05/2004
8Candidiasis (Moniliasis)
01/2014 - 04/2004
7Rheumatoid Arthritis
10/2013 - 07/2003
5Fatigue
01/2015 - 01/2007
5Porcine Reproductive and Respiratory Syndrome (PRRS)
04/2014 - 08/2008
5Chronic Granulomatous Disease
03/2014 - 02/2010
5Necrosis
11/2011 - 11/2003
4Atherosclerosis
04/2015 - 02/2006
4Q Fever (Fever, Q)
01/2015 - 01/2013
4Arthritis (Polyarthritis)
12/2013 - 09/2007
4Candidemia
03/2012 - 08/2004
4Lyme Disease (Disease, Lyme)
01/2012 - 06/2010
4Tuberculosis (Tuberculoses)
02/2007 - 02/2002
3Chronic Mucocutaneous Candidiasis
09/2015 - 12/2010
3Mevalonate Kinase Deficiency
02/2015 - 05/2004
3Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2014 - 01/2007
3Endotoxemia
11/2012 - 05/2007
3Bacterial Infections (Bacterial Infection)
07/2012 - 08/2005
3Septic Shock (Toxic Shock Syndrome)
07/2012 - 10/2007
3Pneumonia (Pneumonitis)
07/2012 - 04/2007
3Multiple Organ Failure (MODS)
07/2012 - 07/2004
3Schnitzler Syndrome
12/2011 - 12/2007
3Crohn Disease (Crohn's Disease)
09/2011 - 01/2008
3Insulin Resistance
12/2010 - 06/2006
3Pulmonary Tuberculosis
01/2010 - 08/2005
3Shock
10/2009 - 12/2002
3Abscess
04/2007 - 12/2002
3Dengue Hemorrhagic Fever
08/2005 - 01/2002
2Plague (Bubonic Plague)
02/2014 - 01/2009
2Vulvovaginal Candidiasis
01/2014 - 10/2009
2Gout
12/2013 - 01/2012
2Anorexia
12/2013 - 08/2005
2Obesity
12/2010 - 06/2006
2Communicable Diseases (Infectious Diseases)
03/2010 - 12/2005
2Dengue (Dengue Fever)
04/2009 - 08/2005
2Familial Mediterranean Fever (Periodic Disease)
03/2007 - 01/2007
2Hyperlipoproteinemias
02/2006 - 08/2004
2Body Weight (Weight, Body)
07/2004 - 12/2003
1Pain (Aches)
01/2015

Drug/Important Bio-Agent (IBA)

20CytokinesIBA
01/2015 - 01/2002
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009 - 01/2002
12Interleukin-1 (Interleukin 1)IBA
01/2015 - 01/2002
9Interleukin-6 (Interleukin 6)IBA
02/2014 - 01/2002
8Interleukin-1beta (Interleukin 1 beta)IBA
01/2015 - 01/2002
7Pattern Recognition ReceptorsIBA
04/2014 - 08/2008
7Interleukin-18 (Interleukin 18)IBA
07/2012 - 11/2003
6Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015 - 08/2008
5Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2015 - 01/2002
5Interleukin-17 (Interleukin 27)IBA
08/2014 - 08/2010
5Interferon-gamma (Interferon, gamma)IBA
01/2014 - 12/2002
5Toll-Like Receptor 4IBA
08/2012 - 07/2003
5C-Reactive ProteinIBA
07/2012 - 02/2002
5InterleukinsIBA
12/2010 - 12/2002
5Lipoproteins (Lipoprotein)IBA
01/2009 - 04/2004
4LigandsIBA
04/2014 - 06/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2014 - 02/2010
4dectin 1IBA
10/2011 - 10/2009
4Immunoglobulin D (IgD)IBA
05/2011 - 05/2004
4Interleukin-12 (IL 12)IBA
01/2011 - 11/2003
3InterferonsIBA
06/2013 - 11/2011
3ZymosanIBA
11/2012 - 07/2004
3Interleukin-10 (Interleukin 10)IBA
02/2012 - 05/2007
3Uric Acid (Urate)IBA
01/2012 - 11/2010
3Toll-Like Receptor 2IBA
09/2011 - 06/2010
3autosomal dominant familial Periodic feverIBA
05/2011 - 01/2007
3Caspase 1 (ICE Protease)IBA
01/2011 - 12/2009
3Anti-Bacterial Agents (Antibiotics)IBA
08/2010 - 04/2007
3Complement System Proteins (Complement)IBA
11/2009 - 11/2003
3AntibodiesIBA
04/2009 - 07/2003
3LeptinIBA
04/2009 - 02/2002
3Messenger RNA (mRNA)IBA
01/2008 - 07/2004
2Acute Q feverIBA
09/2015 - 01/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2015 - 12/2003
2mevalonate kinaseIBA
02/2015 - 11/2008
2Biological Markers (Surrogate Marker)IBA
01/2015 - 01/2014
2Serine Proteases (Serine Protease)IBA
01/2015 - 12/2009
2NADP (NADPH)IBA
03/2014 - 02/2010
2Cytokine Receptors (Cytokine Receptor)IBA
01/2014 - 02/2012
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2013 - 11/2003
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2013 - 07/2004
2Immunoglobulin G (IgG)IBA
05/2013 - 07/2004
2Interleukin-8 (Interleukin 8)IBA
02/2012 - 03/2007
2Caspase 12IBA
01/2012 - 01/2009
2Interleukin-23 (Interleukin 23)IBA
11/2011 - 01/2011
2Insulin (Novolin)FDA Link
12/2010 - 01/2007
2Vitamin A (Retinol)FDA LinkGeneric
01/2010 - 04/2002
2ZincIBA
01/2010 - 04/2002
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
11/2009 - 10/2004
2Apolipoproteins E (ApoE)IBA
01/2009 - 08/2004
2Carrier Proteins (Binding Protein)IBA
01/2007 - 06/2006
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2005 - 01/2004
1Histones (Histone)IBA
04/2015
1tocilizumabFDA Link
02/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2015
1Interleukin-2 (IL2)IBA
01/2015

Therapy/Procedure

7Immunotherapy
09/2015 - 04/2004
2Immunomodulation
08/2014 - 12/2003